Hector Bonilla
Overview
Explore the profile of Hector Bonilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eastin E, Machnik J, Stiles L, Larsen N, Seliger J, Geng L, et al.
Clin Auton Res
. 2025 Feb;
PMID: 39907931
Purpose: Autonomic dysfunction is a common and often debilitating feature of long-COVID (LC), however, studies evaluating frequency and severity of chronic autonomic dysfunction in LC are limited. We utilized an...
2.
Shah D, Thaweethai T, Karlson E, Bonilla H, Horne B, Mullington J, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2455430.
PMID: 39841477
Importance: A substantial number of individuals worldwide experience long COVID, or post-COVID condition. Other postviral and autoimmune conditions have a female predominance, but whether the same is true for long...
3.
Quach T, Miglis M, Tian L, Bonilla H, Yang P, Grossman L, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772087
Introduction: COVID-19 vaccinations reduce the severity and number of symptoms for acute SARS-CoV-2 infections and may reduce the risk of developing Long COVID, also known as post-acute sequelae of SARS-CoV-2...
4.
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution
Hamlin R, Pienkos S, Chan L, Stabile M, Pinedo K, Rao M, et al.
Sci Transl Med
. 2024 Nov;
16(773):eadr1032.
PMID: 39536117
Sex differences have been observed in acute coronavirus disease 2019 (COVID-19) and Long Covid (LC) outcomes, with greater disease severity and mortality during acute infection in males and greater proportions...
5.
Hamlin R, Pienkos S, Chan L, Stabile M, Pinedo K, Rao M, et al.
bioRxiv
. 2024 Jul;
PMID: 38948732
Sex differences have been observed in acute COVID-19 and Long COVID (LC) outcomes, with greater disease severity and mortality during acute infection in males and a greater proportion of females...
6.
Geng L, Bonilla H, Hedlin H, Jacobson K, Tian L, Jagannathan P, et al.
JAMA Intern Med
. 2024 Jun;
184(9):1024-1034.
PMID: 38848477
Importance: There is an urgent need to identify treatments for postacute sequelae of SARS-CoV-2 infection (PASC). Objective: To assess the efficacy of a 15-day course of nirmatrelvir-ritonavir in reducing the...
7.
Shankar V, Wilhelmy J, Curtis E, Michael B, Cervantes L, Mallajosyula V, et al.
bioRxiv
. 2024 May;
PMID: 38746454
More than 65 million individuals worldwide are estimated to have Long COVID (LC), a complex multisystemic condition, wherein patients of all ages report fatigue, post-exertional malaise, and other symptoms resembling...
8.
Bonilla H, Tian L, Marconi V, Shafer R, McComsey G, Miglis M, et al.
Int Immunopharmacol
. 2023 Oct;
124(Pt B):110966.
PMID: 37804660
The global prevalence of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) stands at approximately 43 % among individuals who have previously had acute COVID-19. In contrast, in the United States, the...
9.
Thaweethai T, Jolley S, Karlson E, Levitan E, Levy B, McComsey G, et al.
JAMA
. 2023 Jun;
329(22):1934-1946.
PMID: 37278994
Importance: SARS-CoV-2 infection is associated with persistent, relapsing, or new symptoms or other health effects occurring after acute infection, termed postacute sequelae of SARS-CoV-2 infection (PASC), also known as long...
10.
Bonilla H, Peluso M, Rodgers K, Aberg J, Patterson T, Tamburro R, et al.
Front Immunol
. 2023 Mar;
14:1129459.
PMID: 36969241
Although most individuals recover from acute SARS-CoV-2 infection, a significant number continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the unexplained symptoms that are frequently referred to as...